Are two doses of misoprostol after mifepristone for early abortion better than one?

被引:20
作者
Coyaji, K.
Krishna, U.
Ambardekar, S.
Bracken, H.
Raote, V.
Mandlekar, A.
Winikoff, B.
机构
[1] Gynuity Hlth Projects, New York, NY 10010 USA
[2] KEM Hosp, Dept Obstet & Gynaecol, Pune, Maharashtra, India
[3] Larsen & Toubro Hlth Ctr, Bombay, Maharashtra, India
关键词
India; medical abortion; mifepristone; misoprostol; EARLY MEDICAL ABORTION; EARLY-PREGNANCY TERMINATION; RANDOMIZED-TRIAL; VAGINAL MISOPROSTOL; UNITED-STATES; EFFICACY; ACCEPTABILITY; WOMEN; GESTATION; REGIMENS;
D O I
10.1111/j.1471-0528.2006.01208.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The objective of this study was to determine if a repeat dose of misoprostol following mifepristone or a single dose of misoprostol increases the efficacy of medical termination of pregnancy. Design Randomised, placebo controlled trial. Setting K.E.M. Hospital, Pune, India, and the Health Centre, Larsen and Toubro Limited, Mumbai, India. Sample A total of 300 women seeking an abortion with amenorrhoea of 8 weeks or less. Methods Women were randomised to receive one or two doses of 400 microgram oral misoprostol at the clinic 48 hours after administration of 200 mg mifepristone. Main outcome measure Complete abortion without surgical intervention. Results The repeat administration of misoprostol 400 microgram improved the complete abortion rate from 86 to 92% and significantly reduced the rate of continuing pregnancy from 7 to 1%. Almost all the women who were administered the additional dose of misoprostol were either very satisfied (58%) or satisfied (37%) with the method. Conclusion While an additional oral dose of 400 microgram misoprostol did not significantly increase the rate of complete abortion without surgical intervention, the additional dose did significantly reduce the rate of continuing pregnancies without compromising the acceptability and ease of use of the method.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 21 条
[1]  
Ashok PW, 2002, BJOG-INT J OBSTET GY, V109, P1281, DOI 10.1046/j.1471-0528.2002.02156.x
[2]  
Aubeny E, 1995, Int J Fertil Menopausal Stud, V40 Suppl 2, P85
[3]   The medical abortion experiences of married and unmarried women in Tunis, Tunisia [J].
Blum, J ;
Hajri, S ;
Chélli, H ;
Ben Mansour, F ;
Gueddana, N ;
Winikoff, B .
CONTRACEPTION, 2004, 69 (01) :63-69
[4]   Home use of two doses of misoprostol after mifepristone for medical abortion: A pilot study in Sweden and France [J].
Clark, WH ;
Hassoun, D ;
Gemzell-Danielsson, K ;
Fiala, C ;
Winikoff, B .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2005, 10 (03) :184-191
[5]   A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion [J].
Creinin, MD ;
Fox, MC ;
Teal, S ;
Chen, A ;
Schaff, EA ;
Meyn, LA .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (05) :851-859
[6]   Can women in less-developed countries use a simplified medical abortion regimen? [J].
Elul, B ;
Hajri, S ;
Nguyen, TNN ;
Ellertson, C ;
Ben Slama, C ;
Pearlman, E ;
Winikoff, B .
LANCET, 2001, 357 (9266) :1402-1405
[7]   The efficacy of medical abortion: A meta-analysis [J].
Kahn, JG ;
Becker, BJ ;
Maclsaa, L ;
Amory, JK ;
Neuhaus, J ;
Olkin, I ;
Creinin, MD .
CONTRACEPTION, 2000, 61 (01) :29-40
[8]   THE EFFECT OF DOSE OF MIFEPRISTONE AND GESTATION ON THE EFFICACY OF MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL [J].
MCKINLEY, C ;
THONG, KJ ;
BAIRD, DT .
HUMAN REPRODUCTION, 1993, 8 (09) :1502-1505
[9]   Is home-based administration of prostaglandin safe and feasible for medical abortion? - Results from a multisite study in Vietnam [J].
Ngoc, NTN ;
Nhan, VQ ;
Blum, J ;
Mai, TTP ;
Durocher, JM ;
Winikoff, B .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2004, 111 (08) :814-819
[10]   Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam [J].
Ngoc, NTN ;
Winikoff, B ;
Clark, S ;
Ellertson, C ;
Am, KN ;
Hieu, DT ;
Elul, B .
INTERNATIONAL FAMILY PLANNING PERSPECTIVES, 1999, 25 (01) :10-+